Horizon Therapeutics to Present at UBS Global Life Sciences Conference

Horizon Therapeutics to Present at UBS Global Life Sciences Conference

09/19/08
Horizon Therapeutics to Present at UBS Global Life Sciences ConferencePALO ALTO, Calif., September 19, 2008 - Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that it will present a corporate overview at the UBS Global Life Sciences Conference in New York on Thursday, September 25 at 1:30 p.m. ET at the Grand Hyatt Hotel.

About Horizon Therapeutics
Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the company and its products, please visit www.horizontherapeutics.com.

Contact:
Geoff Curtis
WeissComm Partners, Inc.
312-284-4701
gcurtis@wcpglobal.com